Sangamo Therapeutics

0.3001
+0.0400
+15.38%
SGMO
 0.3130 0.2504 877.55万股总市值 1.24亿
 0.2311 2.12% 253.69万市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
用户头像
Sangamo Therapeutics(SGMO)
03-31 05:45  
$Sangamo Therapeutics(SGMO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-26-022029  Act: 34  Size: 34 MB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
03-31 05:35  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-26-022006  Act: 34  Size: 326 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-27 10:55  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-26-000004  Size: 8 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-27 10:55  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-26-000004  Size: 8 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-27 10:55  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-26-000004  Size: 8 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-27 10:55  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002089213-26-000004  Size: 8 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-27 10:55  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-26-000004  Size: 8 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-04 21:45  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001193125-26-036792  Act: 34  Size: 658 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-04 21:35  
$Sangamo Therapeutics(SGMO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-26-036786  Act: 33  Size: 660 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-04 05:15  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, item 8.01 Accession Number: 0001001233-26-000005  Act: 34  Size: 6 MB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-03 22:15  
$Sangamo Therapeutics(SGMO)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001193125-26-034556  Act: 34  Size: 155 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
02-03 22:05  
$Sangamo Therapeutics(SGMO)$ 8-K Current report, items 2.02 and 5.02 Accession Number: 0001001233-26-000002  Act: 34  Size: 146 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:25  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002089213-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001675687-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001877368-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
01-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001779092-26-000002  Size: 6 KB 网页链接
用户头像
Sangamo Therapeutics(SGMO)
2025-11-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002041855-25-000006  Size: 6 KB 网页链接
1
用户头像
Sangamo Therapeutics(SGMO)
2025-11-27 05:15  
$Sangamo Therapeutics(SGMO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001947007-25-000006  Size: 6 KB 网页链接